Publication: Lack of resistant mutation development after receiving short-course zidovudine plus lamivudine to prevent mother-to-child transmission
| dc.contributor.author | Kulkanya Chokephaibulkit | en_US |
| dc.contributor.author | Pongsakdi Chaisilwattana | en_US |
| dc.contributor.author | Nirun Vanprapar | en_US |
| dc.contributor.author | Wanatpreeya Phongsamart | en_US |
| dc.contributor.author | Ruengpung Sutthent | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2018-06-21T08:15:41Z | |
| dc.date.available | 2018-06-21T08:15:41Z | |
| dc.date.issued | 2005-07-22 | en_US |
| dc.description.abstract | A short-course regimen of zidovudine plus lamivudine starting from 34 weeks' gestation in pregnant women to prevent mother-to-child HIV infection, and discontinued after delivery, was evaluated for the development of resistance at 6 weeks postpartum. No resistant mutation was found in 32 women. One of the three infected infants carried the M184V and K219Q mutations. | en_US |
| dc.identifier.citation | AIDS. Vol.19, No.11 (2005), 1231-1233 | en_US |
| dc.identifier.doi | 10.1097/01.aids.0000176226.63732.71 | en_US |
| dc.identifier.issn | 02699370 | en_US |
| dc.identifier.other | 2-s2.0-23044509223 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/16569 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=23044509223&origin=inward | en_US |
| dc.subject | Immunology and Microbiology | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Lack of resistant mutation development after receiving short-course zidovudine plus lamivudine to prevent mother-to-child transmission | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=23044509223&origin=inward | en_US |
